Sangamo Therapeutics Inc (NASDAQ:SGMO)

Delayed Data
As of 3:59pm ET
 +0.0209 / +4.86%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The median estimate represents a +343.56% increase from the last price of 0.45.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 51.36%
Growthannually 29.36%


Growthquarterly 41.99%
Growthannually 64.30%
Key to the earnings and sales forecast charts.